• Explore /
  • Poster
  • / The efficacy and safety of sunitinib in patients with advanced well-differentiated pancreatic neuroendocrine tumors.

The efficacy and safety of sunitinib in patients with advanced well-differentiated pancreatic neuroendocrine tumors.

Abstract Poster

Authors

null

Eric Raymond

Hopital Paris Saint-Joseph, Paris, France

Eric Raymond , Matthew H. Kulke , Shukui Qin , Michael Schenker , Antonio Cubillo , Wenhui Lou , Jiri Tomasek , Espen Thiis-Evensen , Jianming Xu , Dr. Karoly Racz , Adina E Croitoru , Mustafa Khasraw , Eva Sedlackova , Ivan Borbath , Paul Ruff , Paul Eliezer Oberstein , Tetsuhide Ito , Kathrine C. Fernandez , Brad Rosbrook , Nicola Fazio

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01525550

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 380)

DOI

10.1200/JCO.2017.35.4_suppl.380

Abstract #

380

Poster Bd #

H6

Abstract Disclosures

Similar Posters

First Author: John Raymond Zalcberg

First Author: Robin Lewis Jones

First Author: Fengying Wu

First Author: Antoine Thiery-Vuillemin